The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Risk factor thresholds: their existence under scrutiny
Open accessAbstract
Interventions to lower blood pressure, serum cholesterol, and other risk factors reduce the risk of cardiovascular disease regardless of initial levels.It follows, say Malcolm Law and Nicholas Wald, that the goal is not to "normalise" risk factors but to reduce them as much as possible.This means targeting everyone at high risk, as determined by age or known cardiovascular disease rather than by the level of the risk factors Physiological variables such as blood pressure, serum cholesterol, body mass index, and bone mineral density are important in the aetiology of common diseases.They are not direct environmental causes of disease, like smoking, but they may be seen as biochemical or biophysical variables, under partial genetic control, that are intermediates between environmental factors and disease itself.It is known that risk can be reduced by lowering high levels of these variables by drug treatment or lifestyle change.But there is a view that changing the average values of these physiological variables is not worth while, a view that implies the presence of thresholds in the dose-response relations between the level of the variable and the risk of disease.This view is reinforced by terminology that regards extreme values as indicating a disease state (such as hypertension, hypercholesterolaemia, osteoporosis, and obesity) and average values as being "normal" (normotensive, normocholesterolaemia).Clinical guidelines specify risk factor thresholds 1-5 ; these have been set at successively lower levels over time and redefined as "action levels" but they still deny treatment below specified values.We examine seven important dose-response relations to determine whether it is useful to impose risk factor thresholds or whether there are better ways to identify patients who should be treated. MethodsWe examined seven dose-response relations between physiological variables and risk of disease that are medically important and for which a large body of data was available: (i-iii) ischaemic heart disease and blood pressure, serum cholesterol, and body mass index; (iv) stroke and blood pressure; (v) diabetes and body mass index; (vi) neural tube defects and maternal plasma folate; and (vii) hip fracture and bone mineral density.For each relation we used a published meta-analysis of cohort studies if one was available, 6 otherwise the largest single cohort study.[7][8][9][10][11] Dividing each cohort into subgroups (usually fifths) defined by ranked values of the physiological variables, we plotted the risk of disease (vertical axis) against the level of the risk factor (horizontal axis), using the subgroups and measure of risk (incidence, mortality, or relative risk) adopted in the original papers.Randomised trials of risk factor modification were available for four of these seven dose-response relations [12][13][14][15][16][17][18][19][20][21][22][23][24] ; we examined these to assess whether they supported the conclusions from the observational studies. The dose-response relations
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Sacks, F. M., Pfeffer, M. A., Moye, L. A., Rouleau, J. L., Rutherford, J. D., Cole, T. G., Brown, L., Warnica, J. W., Arnold, J. M. O., Wun, C.-C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351401 · Cited by 7,439
Intravenous Fluids and Acute Kidney Injury
Ding, X., Cheng, Z., & Qian, Q. (2017) · Blood Purification · doi:10.1159/000452702 · Cited by 6,827
(1998) · New England Journal of Medicine · doi:10.1056/nejm199811053391902 · Cited by 5,261
Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236
Blood pressure, stroke, and coronary heart disease
Collins, R., Peto, R., MacMahon, S., Godwin, J., Qizilbash, N., Collins, R., MacMahon, S., Hebert, P., Eberlein, K. A., Taylor, J. O., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)90944-z · Cited by 4,491
SCANDINAVIANSIMVASTATINSURVIVAL (1994) · The Lancet · doi:10.1016/s0140-6736(94)90566-5 · Cited by 3,645
Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study
(1991) · The Lancet · doi:10.1016/0140-6736(91)90133-a · Cited by 3,472
Cited by
Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
Cannon, C. P., Braunwald, E., McCabe, C. H., Rader, D. J., Rouleau, J. L., Belder, R., Joyal, S. V., Hill, K. A., Pfeffer, M. A., & Skene, A. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040583 · Cited by 4,938
Stroke risk factors, genetics, and prevention
Boehme, A. K., Esenwa, C., & Elkind, M. S. V. (2017) · Circulation Research · doi:10.1161/circresaha.116.308398 · Cited by 1,952
Law, M. R., Wald, N. J., Morris, J. K., & Jordan, R. E. (2003) · BMJ · doi:10.1136/bmj.326.7404.1427 · Cited by 1,232
Self-citationHuxley, R. R., Lopez, F. L., Folsom, A. R., Agarwal, S. K., Loehr, L. R., Soliman, E. Z., Maclehose, R., Konety, S., & Alonso, A. (2011) · Circulation · doi:10.1161/circulationaha.110.009035 · Cited by 697
Blood glucose and risk of cardiovascular disease in the Asia Pacific region.
Asia Pacific Cohort Studies Collaboration (2004) · Diabetes Care · doi:10.2337/diacare.27.12.2836 · Cited by 302
Metadata
- Authors
- Law, M. R., & Wald, N. J.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2002-06-29
- Volume
- 324
- Issue
- 7353
- Pages
- 1570-1576
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W1544587904
- Cited by
- 268
- References
- 58
- FWCI
- 24.66
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Risk factor thresholds: their existence under scrutiny. https://app.cochat.ai/papers/10.1136/bmj.324.7353.1570
- The paper
- Law, M. R., & Wald, N. J. (2002). Risk factor thresholds: their existence under scrutiny. BMJ. https://doi.org/10.1136/bmj.324.7353.1570
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.